";s:4:"text";s:3962:" 0000062922 00000 n
0000053564 00000 n
We also assessed the effect of moving from 0 dose to a fixed 10 g or 20 g CPZ equivalent dose.
0000051190 00000 n
0000051005 00000 n
Horvitz-Lennon, M., O’Malley, A., Frank, R. & Normand, S.-L.
You can also search for this author in Donohue, J. et al. trailer
Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. We then identified individuals who experienced a weight gain of 7% or more. Data from the cohort of 272 antipsychotic-naïve youth demonstrated significant weight gain over the first 3 months of treatment with all SGAs, including aripiprazole: 4.4 kg, 58.4% gaining ≥7% weight; risperidone: 5.3 kg, 64.4% gaining ≥7% weight; quetiapine: 6.1 kg, 55.6% gaining ≥ 7% weight; and olanzapine: 8.5 kg, 84.4% gaining ≥ 7% weight during the 12 week period. Using a unique statistical approach, they found that people taking the drug olanzapine had the highest risk of weight gain. & Arndt, S. Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach.
0000050558 00000 n
The term high-risk antipsychotics used throughout this article refers to Clozaril and Zyprexa and, in some cases, Seroquel and Risperdal. Unable to load your collection due to an error Jin, H. et al. Abilify [package insert], Geodon [package insert]. However this quantity is itself estimated and may not be the best conversion scale to use. This model produced odds ratios characterizing the odds of weight gain when randomized to a specific SGA (regardless of dose) relative to the odds when randomized to placebo; the as-treated regression provided the odds of weight gain for each 10 g CPZ increase in dose. 0000064600 00000 n
0000063671 00000 n
0000060539 00000 n
0000009085 00000 n
A meta-analysis of randomized trials conducted between 1955 and 2012 that evaluated efficacy and tolerability of 15 antipsychotics, both first generation antipsychotics (FGA) and SGAs, found that olanzapine, followed by zotepine and clozapine were associated the highest risk for weight gain, followed in descending order by quetiapine, risperidone, and paliperidone.Despite the substantial health burden associated with SGAs, several features of the metabolic risk of SGAs remain poorly understood. Hert, M. D. et al. doi: 10.1002/14651858.CD006654.pub2.McDonagh M, Peterson K, Carson S, Fu R, Thakurta S.Portland (OR): Oregon Health & Science University; 2010 Jul.Higgins-Chen AT, Boks MP, Vinkers CH, Kahn RS, Levine ME.Biol Psychiatry.
Citrome, L. et al. risperidone -can ↑ weight by 2 kg at 10 weeks, then 2.3kg RISPERDAL after long term treatment-18% of patients & 9% of placebo patients increased >7% from baseline body weight quetiapine-can ↑ weight by 2 kg at 4-8 weeks, 3.5kg at SEROQUEL 18-26 week & 5.6kg at … 2014;40(2):314-26. A randomized, double-blind, placebo-controlled study of 2 dose ranges of paliperidone extended-release in the treatment of subjects with schizoaffective disorder.